T1	Intervention 719 763	switched from CFC albuterol to HFA albuterol
T2	Intervention 876 998	either continue receiving CFC albuterol or to be switched to receive HFA albuterol in a yearlong safety and efficacy trial
T3	Intervention 1222 1314	serial spirometry for 6 hr after the patients self-administered the study drug in the clinic
T4	Intervention 1360 1565	pulse rate, blood pressure, and electrocardiogram (ECG) intervals after dosing with study drug, monitoring adverse events, and performing prestudy and poststudy laboratory testing and physical examinations
